INFORMATION FOR RESEARCHERS
| Established in 1961 by Norman Orentreich, M.D., OFAS is a Private Operating Foundation registered with and classified by the United States Internal Revenue Service as a 4942(j)(3) organization. As such, it is a foundation whose primary activity is to conduct its own research (or social welfare or other programs determined by its governing body or establishment charter). | |
| SOURCE OF FUNDING AND DEDUCTIBILITY OF CONTRIBUTIONS | OFAS is supported by contributions and grants for its own research. Contributions are fully tax-deductible in accordance with IRS regulations under section 501(c)(3). For contributions to OFAS from private foundations, OFAS provides, upon grantor's request, expenditure responsibility report(s) for their compliance with IRS requirements. |
| PUBLICATION | Each year (usually in December), OFAS distributes to supporters and other interested parties a report on research activities. Occasionally, interim communications occur. |
| RESEARCH INTERESTS | OFAS is interested in biomedical research in general, but OFAS research typically is focused on aging, dermatology, endocrinology, and serum markers for human diseases. |
| UNIQUE SCIENTIFIC ASSET | A unique OFAS asset
is a computer-cataloged Serum Treasury. The Treasury consists of:
|
| GRANTS BY OFAS | OFAS generally makes only occasional and limited grants to help fund joint or collaborative research in fields of substantial OFAS research interest. OFAS usually is the initiator of such joint projects. |
|
Submit an outline of proposed joint or collaborative research, including, as a minimum, a brief overview of the current research in the field of interest, a statement of scientific objectives, a protocol summary, curriculum vitae of principal investigator, needed funding, and total estimated project budget. Conforming applications are reviewed at least quarterly. |
|
Amounts vary depending upon the needs, nature and level of OFAS interest in the project. |
|
Recipients are typically at or above post-graduate level in science or medicine at accredited universities or research institutions in the U.S. There is no restriction on citizenship. |
| If you have a research question relating to a human disease or disease prevention factor, for which there is adequate scientific evidence of a serum marker to justify use of the Serum Treasury in pursuit of a definitive answer, please submit your proposal for consideration to: | Rozlyn Krajcik, PhD, RPh Assistant Direrctor of Scientific Affairs OFAS, Biomedical Research Station 855 Route 301 RD 2 Box 375 Cold Spring, NY 10516-9802 Tel: 914.265.4200 Fax: 914.265.4210 E-Mail: ofas1@juno.com |